| Aktsiad | 687,683 mld. | - | KoAct | 0 | Tervishoid | | 3.8.2023 | 23 628,37 | 10,75 | 37,04 |
| Aktsiad | 330,723 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 8973,41 | 5,58 | 62,65 |
| Aktsiad | 305,402 mld. | - | KODEX | 0,45 | Tervishoid | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 13 383,98 | 6,16 | 37,93 |
| Aktsiad | 221,287 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Healthcare - KRW | 15.7.2011 | 52 310,87 | 4,97 | 44,36 |
| Aktsiad | 107,225 mld. | - | Tiger ETF | 0,30 | Tervishoid | NASDAQ Biotechnology Index | 26.8.2014 | 30 836,46 | 5,39 | 23,05 |
| Aktsiad | 103,988 mld. | - | KODEX | 0,09 | Tervishoid | KRX Healthcare - KRW | 28.3.2017 | 23 700,71 | 4,97 | 44,35 |
| Aktsiad | 102,408 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 20 428,09 | 10,42 | 59,10 |
| Aktsiad | 65,854 mld. | - | KODEX | 0,25 | Tervishoid | S&P Health Care Select Sector | 21.3.2023 | 13 485,13 | 5,22 | 23,35 |
| Aktsiad | 63,802 mld. | - | Tiger ETF | 0,49 | Tervishoid | Solactive China Biotech Index | 3.12.2020 | 8574,82 | 4,51 | 39,52 |
| Aktsiad | 58,624 mld. | - | Tiger ETF | 0,45 | Tervishoid | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10 527,94 | 11,39 | 23,58 |
| Aktsiad | 56,217 mld. | - | KB RISE | 0 | Tervishoid | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 15 941,66 | 9,56 | 68,04 |
| Aktsiad | 55,94 mld. | - | KODEX | 0,45 | Tervishoid | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 11 283,10 | 6,85 | 18,67 |
| Aktsiad | 41,084 mld. | 12,763 mln. | SPDR | 0,08 | Tervishoid | S&P Health Care Select Sector | 16.12.1998 | 156,01 | 5,22 | 23,41 |
| Aktsiad | 37,558 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 23 527,19 | 3,30 | 39,30 |
| Aktsiad | 31,323 mld. | - | Tiger ETF | 0 | Tervishoid | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 26 297,43 | 0 | 0 |
| Aktsiad | 27,553 mld. | - | Hwabao | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,36 | 3,06 | 30,88 |
| Aktsiad | 20,763 mld. | - | KODEX | 0,25 | Tervishoid | S&P Biotechnology Select Industry | 31.10.2013 | 39 623,79 | 0 | 0 |
| Aktsiad | 18,428 mld. | - | NH-Amundi | 0 | Tervishoid | | 26.11.2024 | 16 210,64 | 5,43 | 37,48 |
| Aktsiad | 18,107 mld. | - | E Fund | 0 | Tervishoid | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,38 | 3,37 | 26,68 |
| Aktsiad | 17,237 mld. | 285 166,7 | Vanguard | 0,09 | Tervishoid | MSCI US IMI 25/50 Health Care | 26.1.2004 | 288,78 | 4,95 | 23,18 |
| Aktsiad | 16,064 mld. | - | KoAct | 0,50 | Tervishoid | | 11.11.2025 | 10 384,86 | 6,94 | 0 |
| Aktsiad | 13,015 mld. | - | KB RISE | 0 | Tervishoid | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 17 974,39 | 4,90 | 40,16 |
| Aktsiad | 9,02 mld. | - | ACE | 0,45 | Tervishoid | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 13 366,83 | 4,16 | 27,36 |
| Aktsiad | 8,992 mld. | - | Kiwoom | 0,49 | Tervishoid | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 13 560,88 | 0 | 0 |
| Aktsiad | 8,795 mld. | - | ACE | 0,30 | Tervishoid | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 13 099,10 | 7,56 | 21,85 |
| Aktsiad | 8,459 mld. | 1,896 mln. | iShares | 0,44 | Tervishoid | NYSE Biotechnology (TR) | 5.2.2001 | 174,02 | 5,58 | 24,11 |
| Aktsiad | 8,35 mld. | 9,341 mln. | SPDR | 0,35 | Tervishoid | S&P Biotechnology Select Industry | 31.1.2006 | 125,30 | 5,25 | 0 |
| Aktsiad | 7,469 mld. | - | Tiger ETF | 0,50 | Tervishoid | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 21 459,46 | 2,97 | 21,40 |
| Aktsiad | 7,419 mld. | - | KoAct | 0,50 | Tervishoid | | 3.9.2024 | 12 305,27 | 4,65 | 18,81 |
| Aktsiad | 6,593 mld. | - | Maxwealth | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,51 | 2,65 | 31,19 |
| Aktsiad | 6,559 mld. | - | ChinaAMC | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,80 | 3,00 | 21,32 |
| Aktsiad | 6,405 mld. | - | Bosera | 0,65 | Tervishoid | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,62 | 2,75 | 12,80 |
| Aktsiad | 5,776 mld. | - | NEXT FUNDS | 0,32 | Tervishoid | | 21.3.2008 | 30 870,42 | 1,87 | 24,41 |
| Aktsiad | 5,654 mld. | - | Kiwoom | 0,49 | Tervishoid | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11 680,26 | 4,64 | 18,04 |
| Aktsiad | 5,441 mld. | - | Nippon | 0,19 | Tervishoid | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
| Aktsiad | 5,425 mld. | - | KB RISE | 0,35 | Tervishoid | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 10 238,55 | 9,52 | 21,79 |
| Aktsiad | 4,915 mld. | - | Tiger ETF | 0,40 | Tervishoid | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0 | 0 |
| Aktsiad | 4,782 mld. | - | ICBC | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,25 | 0 | 0 |
| Aktsiad | 4,664 mld. | - | ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,38 | 3,29 | 26,50 |
| Aktsiad | 4,664 mld. | - | ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,38 | 3,29 | 26,50 |
| Aktsiad | 4,562 mld. | - | Invesco | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,62 | 3,45 | 24,61 |
| Aktsiad | 4,501 mld. | 194 017,8 | iShares | 0,40 | Tervishoid | S&P Global 1200 / Health Care -SEC | 13.11.2001 | 99,35 | 4,69 | 22,94 |
| Aktsiad | 4,382 mld. | - | E Fund | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,40 | 0 | 0 |
| Aktsiad | 3,719 mld. | - | Guotai | 0,60 | Tervishoid | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1,01 | 0 | 0 |
| Aktsiad | 3,628 mld. | 1,308 mln. | iShares | 0,38 | Tervishoid | DJ US Select / Medical Equipment | 1.5.2006 | 57,96 | 4,32 | 27,48 |
| Aktsiad | 3,521 mld. | - | Xtrackers | 0,25 | Tervishoid | MSCI World Index / Health Care -SEC | 22.11.2010 | 59,49 | 4,85 | 23,14 |
| Aktsiad | 3,286 mld. | 643 965,8 | iShares | 0,38 | Tervishoid | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 65,48 | 5,22 | 23,47 |
| Aktsiad | 3,187 mld. | - | Fullgoal | 0,60 | Tervishoid | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,39 | 0 | 0 |
| Aktsiad | 2,901 mld. | 149 316,3 | Fidelity | 0,08 | Tervishoid | MSCI US IMI 25/50 Health Care | 21.10.2013 | 74,54 | 5,14 | 23,67 |
| Aktsiad | 2,735 mld. | - | NH-Amundi | 0,45 | Tervishoid | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9115,65 | 3,43 | 26,31 |
| Aktsiad | 2,715 mld. | - | iShares | 0,15 | Tervishoid | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 12,49 | 5,22 | 23,40 |
| Aktsiad | 2,458 mld. | - | Hwabao | 0 | Tervishoid | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | - | 4,76 mld. | 0 | 0 |
| Aktsiad | 2,411 mld. | 48 137,48 | First Trust | 0,54 | Tervishoid | NYSE Arca Biotechnology Index | 19.6.2006 | 213,11 | 3,74 | 25,49 |
| Aktsiad | 2,282 mld. | - | Guotai | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,45 | 3,06 | 30,91 |
| Aktsiad | 1,872 mld. | - | Ping An | 0,60 | Tervishoid | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,36 | 4,10 | 25,08 |
| Aktsiad | 1,679 mld. | - | E Fund | 0,20 | Tervishoid | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,10 | 2,50 | 20,25 |
| Aktsiad | 1,61 mld. | - | Harvest ETFs | 1,06 | Tervishoid | | 19.11.2014 | 7,57 | 4,93 | 21,81 |
| Aktsiad | 1,55 mld. | - | Guotai | 0,60 | Tervishoid | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,88 | 0 | 0 |
| Aktsiad | 1,526 mld. | - | iShares | 0,18 | Tervishoid | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 7,41 | 4,14 | 20,85 |
| Aktsiad | 1,49 mld. | - | Amundi | 0,50 | Tervishoid | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9937,75 | 2,82 | 14,76 |
| Aktsiad | 1,486 mld. | - | Cathay | 1,05 | Tervishoid | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,17 | 3,66 | 18,91 |
| Aktsiad | 1,398 mld. | - | iShares | 0,46 | Tervishoid | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 141,27 | 0 | 0 |
| Aktsiad | 1,368 mld. | - | E Fund | 0,20 | Tervishoid | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,51 | 2,78 | 29,20 |
| Aktsiad | 1,345 mld. | - | E Fund | 0,20 | Tervishoid | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,42 | 4,33 | 29,55 |
| Aktsiad | 1,181 mld. | - | E Fund | 0,20 | Tervishoid | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,66 | 3,12 | 28,62 |
| Aktsiad | 1,156 mld. | 391 987,4 | VanEck | 0,36 | Tervishoid | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 108,57 | 5,10 | 19,71 |
| Aktsiad | 1,138 mld. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 63,04 | 5,43 | 23,65 |
| Aktsiad | 1,138 mld. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 63,04 | 5,43 | 23,65 |
| Aktsiad | 1,079 mld. | - | iShares | 0,40 | Tervishoid | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 9,23 | 4,30 | 23,60 |
| Aktsiad | 1,079 mld. | - | iShares | 0,40 | Tervishoid | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 9,23 | 4,30 | 23,60 |
| Aktsiad | 1,045 mld. | - | Harvest | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,87 | 0 | 0 |
| Aktsiad | 988,336 mln. | 129 249,7 | iShares | 0,38 | Tervishoid | DJ US Select / Pharmaceutical | 1.5.2006 | 89,99 | 4,58 | 22,92 |
| Aktsiad | 963,418 mln. | - | Global X | 0,59 | Tervishoid | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1718,50 | 2,32 | 22,92 |
| Aktsiad | 942,257 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 157,39 | 3,32 | 19,68 |
| Aktsiad | 942,257 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 157,39 | 3,32 | 19,68 |
| Aktsiad | 918,127 mln. | 22 037,43 | First Trust | 0,62 | Tervishoid | StrataQuant Health Care Index | 8.5.2007 | 114,55 | 2,88 | 17,15 |
| Aktsiad | 909,166 mln. | - | iShares | 0,35 | Tervishoid | NASDAQ Biotechnology Index | 19.10.2017 | 8,63 | 0 | 0 |
| Aktsiad | 904,394 mln. | - | Wanjia | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,56 | 3,45 | 24,61 |
| Aktsiad | 882,591 mln. | - | CSOP | 1,50 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,64 | 3,64 | 29,45 |
| Aktsiad | 771,039 mln. | - | Amundi | 0,30 | Tervishoid | MSCI World Index / Health Care -SEC | 19.8.2010 | 487,05 | 7,68 | 29,88 |
| Aktsiad | 755,588 mln. | 94 569,5 | Invesco | 0,40 | Tervishoid | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 32,39 | 3,32 | 21,36 |
| Aktsiad | 742,945 mln. | - | iShares | 0,46 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 118,30 | 4,15 | 21,38 |
| Aktsiad | 732,758 mln. | 265 978,5 | iShares | 0,38 | Tervishoid | DJ US Select / Health Care Providers | 1.5.2006 | 44,74 | 2,51 | 18,27 |
| Aktsiad | 686,52 mln. | - | Cathay | 0,41 | Tervishoid | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,35 | 0 | 0 |
| Aktsiad | 674,163 mln. | - | SPDR | 0,18 | Tervishoid | MSCI Europe Health Care Index - EUR | 5.12.2014 | 235,23 | 4,14 | 20,85 |
| Aktsiad | 650,74 mln. | - | SPDR | 0,30 | Tervishoid | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 68,68 | 5,08 | 25,68 |
| Aktsiad | 639,966 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 70,42 | 4,71 | 44,44 |
| Aktsiad | 639,966 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 70,42 | 4,71 | 44,44 |
| Aktsiad | 616,415 mln. | - | iShares | 0,18 | Tervishoid | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,90 | 4,16 | 22,04 |
| Aktsiad | 607,894 mln. | 647 110,7 | Direxion | 0,93 | Tervishoid | S&P Biotechnology Select Industry | 28.5.2015 | 167,54 | 0 | 0 |
| Aktsiad | 582,349 mln. | - | ChinaAMC | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,89 | 2,65 | 31,16 |
| Aktsiad | 572,52 mln. | - | iShares | 0,66 | Tervishoid | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 71,45 | 0 | 0 |
| Aktsiad | 564,144 mln. | - | SPDR | 0,15 | Tervishoid | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 48,19 | 5,22 | 23,41 |
| Aktsiad | 532,796 mln. | - | Fullgoal | 0,60 | Tervishoid | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,93 | 0 | 0 |
| Aktsiad | 527,191 mln. | - | China Southern | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,16 | 2,97 | 21,35 |
| Aktsiad | 482,543 mln. | - | Guotai | 0,60 | Tervishoid | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,73 | 3,51 | 27,58 |
| Aktsiad | 436,064 mln. | - | Invesco | 0,40 | Tervishoid | NASDAQ / Biotechnology | 6.11.2014 | 61,66 | 5,40 | 22,79 |
| Aktsiad | 417,267 mln. | - | China Southern | 0,20 | Tervishoid | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,66 | 3,12 | 28,62 |
| Aktsiad | 410,269 mln. | - | Invesco | 0,14 | Tervishoid | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 768,82 | 5,10 | 22,93 |
| Aktsiad | 406,02 mln. | - | Maxwealth | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,47 | 0 | 0 |